New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
12:31 EDTULTA, CELG, CTB, GIS, GMCR, SBUX, AROOn The Fly: Midday Wrap
Stocks on Wall Street traded in a narrow band on either side of the flat-line in the early going, as the news flow continues to be dominated by developments between Russia and Ukraine. Stocks opened in quiet fashion and moved to the upside early in the session. The market was unable to hold its gains, however, and reversed course following a report that indicated that consumer sentiment has fallen this month. The averages crossed back into positive territory right before noon, but the market has remained in a narrow range throughout the morning's swings. ECONOMIC EVENTS: In the U.S., producer prices fell 0.1% overall in February, versus an expected increase of 0.2%. The core reading, which excludes food and energy, fell 0.2%, versus an expected increase of 0.1%. The Reuters/University of Michigan Consumer Sentiment Survey for March unexpectedly dropped to a four-month low of 79.9. The preliminary reading for the month was expected by analysts to have come in at 81.8, which would have been a slight bump from the prior 81.6 figure. In Europe, one person reportedly died and several were injured after violent clashes in the Ukrainian city of Donetsk amid demonstrations from those opposed to Russia’s military intervention in Crimea. Also, reports indicated the Russian military conducted another military exercise near Ukraine on Thursday. COMPANY NEWS: Shares of single-serve coffee machine maker Keurig Green Mountain (GMCR) rose nearly 9% after the company agreed to new terms in its deal with coffee giant Starbucks (SBUX). Research firm Buckingham said its views Keurig's amended deal with Starbucks as a positive event for both companies. The new agreement lets Keurig pursue additional premium unlicensed brands and provides Starbucks an opportunity for better margins, said the firm... Shares of teen retailer Aeropostale (ARO) fell almost 14% after its fourth quarter results and first quarter outlook missed analysts' consensus expectations. The retailer also entered a financing deal with private equity firm Sycamore Partners for a strategic partnership and $150M in senior secured credit facilities. Aeropostale will also issue convertible preferred stock to Sycamore that gives the firm the right to acquire up to 5% of the company's common stock at an exercise price of $7.25, the closing price of the company's common stock on March 12. MAJOR MOVERS: Among the notable gainers was beauty retailer Ulta Salon (ULTA), which advanced over 7% after the company’s fourth quarter results beat estimates. Also higher following its quarterly earnings report was tire maker Cooper Tire & Rubber (CTB), which rose nearly 8%. Among the noteworthy losers was Celgene (CELG), which dropped almost 3% after the U.K.'s healthcare guidance body issued new draft guidance on the use of the company's Revlimid drug. Also lower were shares of cereal and packaged foods maker General Mills (GIS), which slid 2% after the company warned its third quarter earnings could miss expectations. INDEXES: Near midday, the Dow was up 1.15, or 0.01%, to 16,110.04, the Nasdaq was up 1.74, or 0.04%, to 4,262.16, and the S&P 500 was virtually unchanged at 1,846.36.
News For GMCR;SBUX;ARO;ULTA;CELG;CTB;GIS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 21, 2014
09:23 EDTCELGCelgene GED-0301 said to have 67% 12-week remission at high dose in trial
Subscribe for More Information
October 20, 2014
13:26 EDTCELGCelgene I&I franchise boosted by Crohn’s trial data, says William Blair
William Blair said it views the preliminary Phase II efficacy and safety data from mongersen in Crohn’s disease reported by Celgene as encouraging. The firm noted that the 10 mg arm did not achieve significance, but the three data points collectively formed a robust dose-response that William Blair said lends support for the drug's proposed mechanism of action. William Blair believes mongersen complements Celgene’s Inflammation & Immunology portfolio and the firm maintains its Outperform rating on the stock, which is up 4% to $91.65 in afternoon trading.
13:21 EDTCELGCelgene reports Phase II data in Crohn’s Disease to be presented at UEG
Subscribe for More Information
October 17, 2014
13:18 EDTCELGLeerink's biotech analyst holds an analyst/industry conference call
Subscribe for More Information
10:43 EDTAROUrban Outfitters slumps after warning on continued retail sales weakness
Subscribe for More Information
08:03 EDTGMCRKeurig receives notification from SEC regarding closing inquiry
Keurig Green Mountain announced it has received notification from the Securities and Exchange Commission that it is closing the previously disclosed four-year inquiry into accounting and disclosure matters at the company and would not be recommending any enforcement action against the company or any of its current or former employees.
October 16, 2014
15:11 EDTSBUXStarbucks confirms plans to roll out mobile ordering in U.S. in 2015
Subscribe for More Information
15:10 EDTCELGAmerican College of Gastroenterology to hold annual meeting
ACG Annual Scientific Meeting 2014 to be held in Philadlephia, PA on October 17-22.
08:06 EDTSBUXAlmunia says political pressure around Google case 'unprecented,' WSJ reports
Subscribe for More Information
October 15, 2014
07:55 EDTSBUXStarbucks checks refute bear case, says Bernstein
Subscribe for More Information
06:14 EDTGMCRKeurig Green Mountain implied volatility of 40 at lower end of index mean range
Subscribe for More Information
October 14, 2014
10:27 EDTULTAUlta Salon volatility elevated into investor meeting
Ulta Salon October call option implied volatility is at 47, November is at 33, December is at 42; compared to its 26-week average of 34 according to Track Data, suggesting large near term price movement into an Investor meeting on October 15.
October 13, 2014
17:24 EDTGISS&P announces changes to the S&P MidCap 400 and S&P SmallCap 600 indices
Subscribe for More Information
11:53 EDTULTAUlta Salon to host investor meeting
Investor meeting to be held in Chicago on October 15 at 11 am. Webcast Link
10:08 EDTCTBOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:26 EDTGMCRAB InBev has studied potential deal to acquire PepsiCo, Bloomberg says
Anheuser-Busch InBev (BUD), which has a history of growth via acquisition and has been speculated to be targeting peer SABMiller (SBMRY), has also studied whether a merger with PepsiCo (PEP) makes sense, according to Bloomberg, citing people familiar with the matter. The report added that one source said no talks between Anheuser-Busch and Pepsi are ongoing, no deal is imminent, and the scenario is among many that has been examined. The report also noted that Albert Fried views Monster Beverage (MNST) and Keurig Green Mountain (GMCR) as other suitable targets for AB InBev. Reference Link
07:15 EDTGISNational Association of Corporate Directors to hold a conference
Subscribe for More Information
07:14 EDTCTBCooper Tire upgraded to Buy from Neutral at SunTrust
Subscribe for More Information
October 10, 2014
08:41 EDTCELGCelgene reports apremilast significantly improved preexisting psoriasis in study
Subscribe for More Information
08:39 EDTCELGCelgene says data show Apremilast treatment resulted in improved quality of life
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use